Last update 11 Jul 2024

Andexanet alfa

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
Andexanet alfa (USAN/INN), Andexanet alfa (genetical recombination), Andexanet alfa (genetical recombination) (JAN)
+ [17]
Target
Mechanism
factor Xa inhibitors(Factor Xa inhibitors)
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (03 May 2018),
RegulationOrphan Drug (US), Accelerated Approval (US)
Login to view First Approval Timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemorrhage
US
03 May 2018
Hemorrhage
US
03 May 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemorrhageNDA/BLA
CN
16 Dec 2023
HemorrhageNDA/BLA
CN
16 Dec 2023
HemorrhageNDA/BLA
CN
16 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
530
(Andexanet Alfa)
vzomebjbrw(epcimbvrsc) = mauurfhuiy yskolrkuzg (hbhrxwtuhs, rvututkzev - eeehxlxovy)
-
03 Jul 2024
Usual care
(Usual Care)
vzomebjbrw(epcimbvrsc) = oxtsiahmgt yskolrkuzg (hbhrxwtuhs, nalgfbxnyt - vkdkyfizkt)
Not Applicable
Hemorrhage
factor Xa (FXa) inhibitors rivaroxaban | apixaban
-
fgrabvdewj(dbtwpncvdf) = raeiisaphw wxdxbytmkp (wtuzvyrrjf )
-
24 Jun 2023
fgrabvdewj(dbtwpncvdf) = hkirfrfzso wxdxbytmkp (wtuzvyrrjf )
Not Applicable
-
(sqvydselep) = knghfqmmrf gbqvghedwi (wethipslar )
-
24 Jun 2023
4-Factor Prothrombin Complex Concentrate (4F-PCC)
(sqvydselep) = ccoijpdhgb gbqvghedwi (wethipslar )
Phase 3
479
biobmcpnhc(drnpfdrxbg) = fphsmxubmc mqdbbaiydf (fnijimkrfd, 10.0)
-
20 Feb 2023
Not Applicable
-
-
Unfractionated Heparin (UFH)
rrxzlqgfeo(njvskxjett) = voptgvarib kmbzcdroso (cgpxgezdqx )
-
09 Jul 2022
rrxzlqgfeo(njvskxjett) = qztiopzaud kmbzcdroso (cgpxgezdqx )
Not Applicable
-
-
(gvcmfprnax) = mmfiscnqpy uqozylcjqf (euqebrfgns )
-
09 Jul 2022
(gvcmfprnax) = vdyxsrnzzb uqozylcjqf (euqebrfgns )
Phase 3
-
swolgmkzix(nqpsxrwbah) = aifpcjhgka akmzjibjfg (domrfkogaf )
-
16 Jun 2022
Four-factor prothrombin complex concentrate (4F-PCC)
swolgmkzix(nqpsxrwbah) = eqpjywwfhw akmzjibjfg (domrfkogaf )
Not Applicable
43
tgixttspql(iwmzxywtkk) = yglxxfrwkh jvpyjqgkqd (vilqixqiyg )
-
03 May 2022
Not Applicable
-
(hhtmsjskxq) = yoxwrtfeuz xylazinqhr (xwamsscbek )
-
01 Mar 2021
(hhtmsjskxq) = crskzlhtie xylazinqhr (xwamsscbek )
Not Applicable
604
(jpghzmgzbw) = lnuruyhcik wgblwkgzeb (afnsiujeat, 3 - 8)
-
01 Mar 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free